NEW YORK (TheStreet) -- Shares of these companies were upgraded to buy at TheStreet Ratings on Wednesday: Charles River Laboratories (CRL), Cameco (CCJ), Silvercorp Metals (SVM), Aecom Technology (ACM), Tempur-Pedic (TPX) and FLIR Systems (FLIR).
Charles River Laboratories
The research company reported on Monday fourth-quarter earnings of $27.1 million, or 55 cents a share, a swing from a year-earlier loss of $342.4 million, or $5.94 a share.
"Our checks indicate more closures of pharma GLP Tox facilities are on the horizon. These should signal higher demand for outsourced services," Jefferies analysts wrote in a report Tuesday. "However, that has been the story for 3 years now. Low pricing still signals excess. Perhaps pharma is finally shuttering these labs after prolonged and unsuccessful attempts to sell them to CROs."Shares of Charles River Laboratories were upgraded to buy from hold by TheStreet Ratings. "The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins," TheStreet Ratings wrote. "We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself." Charles River Laboratories has an estimated price-to-earnings ratio for next year of 11.93; the average for biotechnology companies is 28.35. For comparison, United Therapeutics (UTHR) has a lower forward P/E of 6.31 and Techne's (TECH) forward P/E is 20.16. Of the 18 analysts who cover Charles River Laboratories, 14 rated the company a hold. Three analysts gave it a buy rating and one gave it a sell. TheStreet Ratings gives Charles River Laboratories a B grade with a $39.15 price target. The stock closed Tuesday at $35.23 and has risen 28.91% year to date.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV